RNA

Is mRNA a Gene Therapy? Unpacking the Evolving Regulatory Debate

Cynthia A. Challener, Ph.D.; April Stanley, MS MBA

Pharma's Almanac

RNA

What new opportunities are emerging for mRNA technology, and how is the portfolio of applications expanding beyond vaccines?

Pharma's Almanac

RNA

Beyond mRNA Vaccines: The Expanding World of RNA-Based Therapeutics

David Alvaro, Ph.D.

Pharma's Almanac

xRNA

Revolutionizing xRNA Production: The Economic Case for Continuous Manufacturing

Aaron B. Cowley, Ph.D.

ReciBioPharm

New Integrated mRNA Offering

Building on Experience and Investing in an Integrated mRNA Offering

Jessica Madigan; Normand Blais

BIOVECTRA

mRNA Ultra-Cold Chain Management

Ultra-Cold Chain and Supply Chain Management Strategies for mRNA

Eunseo (Ency) Lee, Ph.D; Jungkeun (Henry) Oh; Hanel Hwang

Samsung Biologics

Custom Lipid Nanoparticle Development

The Value of a Custom Lipid Solutions Provider for mRNA Delivery

Lauren Longobardi, Ph.D.; Rima Jaber, Ph.D.; Sebastian Detlefsen, Dr.-Ing.

Evonik

mRNA Manufacturing

Investing in the Future of mRNA Manufacturing

Esther Yoo, Ph.D.

Samsung Biologics

mRNA Manufacturing

Overcoming Bottlenecks in mRNA Manufacturing

Pierre Catignol; Huisub Lim

Samsung Biologics

Column: Technology

mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.; Danielle Alvarez

Pharma's Almanac

mRNA

Leveraging Existing Technologies with New Dedicated Facilities for mRNA Projects

Scott Doncaster; Marc Sauer, Ph.D.

BIOVECTRA

mRNA Manufacturing

Serving an Accelerated Market with mRNA Production

Mark Bamforth

Arranta Bio

Investing in mRNA Production

Michael Wourms

Arranta Bio

mRNA Manufacturing

Limiting Risk In mRNA Development and Production

Doug Kennedy

Arranta Bio

mRNA Manufacturing

Integrating a Fragmented mRNA Supply Chain

Dave Stevens

Arranta Bio

mRNA

Integrated Support Facilitates mRNA Product Development and Commercialization

Michael Wourms; Dave Stevens

Arranta Bio